Asset Intelligence / Hyperliquid Context
Eli Lilly and Company / LLY
Archive-backed market intelligence for LLY: every HIPERWIRE mover article tied to this asset, plus a client-refreshed live market panel.
LLY tracks the value of 1 share of common stock in Eli Lilly and Company. Eli Lilly develops and manufactures pharmaceuticals, including treatments for diabetes, oncology, immunology, and other therapeutic areas.
Live Structure
Market Status
Loading current market structure...
- Builderxyz
- Categorystock
- Tracked Marketxyz:LLY
- Latest Tweet—
No other live markets from this builder in the current screener.
No same-category alternatives are live in the current screener snapshot.
Archive Summary
Latest Archived Thesis
How to Trade Eli Lilly and Company (LLY) on Hyperliquid
Eli Lilly is the largest pharmaceutical company in the world by revenue, driven by blockbuster GLP-1 drugs Mounjaro and Zepbound that generated $36.5 billion combined in 2025. LLY is now available as a HIP-3 perpetual futures contract on Hyperliquid, giving traders leveraged exposure to one of the most consequential names in biopharma without touching traditional equity markets.
Background reading selected from this asset's symbol, builder context, and archived catalyst coverage.
HIP-3 Explained
HIP-3 makes perpetual futures listing fully permissionless on Hyperliquid. Any builder who stakes 500,000 HYPE can deploy their own perpetual markets — from crypto to commodities, equities, and beyond.
Funding Rates Explained: A Trader's Guide (2026)
Funding rates determine whether you pay or get paid to hold a perpetual futures position. Learn how Hyperliquid calculates hourly funding, read funding rate signals, and use cash-and-carry arbitrage and mean-reversion strategies.